| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/08/2004 | DE10244810A1 Neue Morpholin-überbrückte Indazolderivate New morpholine-bridged indazole derivatives |
| 04/08/2004 | CA2500420A1 Anti-neurodegenerative agents |
| 04/08/2004 | CA2500221A1 Substituted 3-(2,5 -disubstituted) pyridyl-4-aryl pyrroles for treating inflammatory diseases |
| 04/08/2004 | CA2500117A1 Process for preparing haloalkyl pyrimidines |
| 04/08/2004 | CA2499876A1 Piperidine derivatives |
| 04/08/2004 | CA2495338A1 Pyrazole amides for treating hiv infections |
| 04/07/2004 | EP1405922A2 Substrates for beta-lactamase and uses thereof |
| 04/07/2004 | EP1405893A1 Organic electroluminescence device and luminance material |
| 04/07/2004 | EP1404673A1 Technical synthesis method for producing tropenol |
| 04/07/2004 | EP1404668A1 Variolin derivatives and their use as antitumor agents |
| 04/07/2004 | EP1404341A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1307457B1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 04/07/2004 | EP1303282A4 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
| 04/07/2004 | CN1487939A Amido ether substituted imidazoquinolines |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1144845C Contineuous preparing method for quinacridineone |
| 04/07/2004 | CN1144805C Bridged bispidine compounds, its preparing method and intermediate and use for treatment of cardiac arrhythmias |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/06/2004 | US6716990 Process and intermediates for the preparation of imidazopyridines |
| 04/06/2004 | US6716988 Urea substituted imidazopyridines |
| 04/06/2004 | US6716983 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
| 04/06/2004 | US6716979 Including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings; absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings; dye conjugates; reactive dyes |
| 04/06/2004 | US6716868 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 04/06/2004 | US6716854 Treatments for restless legs syndrome |
| 04/06/2004 | US6716853 Degenerative joint disorders; 2-(4'-alkyloxycarbonylaminobi phenyl-4-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxy or the 4,5,6,7-tetrahydro-1h-imidazo(4,5-c)pyridine ring; sulfonylation of ring n with 4-nitrobiphenylsulfonic acid |
| 04/06/2004 | US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
| 04/06/2004 | US6716849 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 04/06/2004 | US6716846 High affinity ligands for nociceptin receptor ORL-1 |
| 04/06/2004 | US6716837 Heterocyclic compounds for the treatment of migraine |
| 04/06/2004 | US6716836 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716832 Arylphenyl-substituted cyclic ketoenols |
| 04/06/2004 | US6716417 Condensation of heated vapor to form aerosol particles |
| 04/06/2004 | US6716416 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |
| 04/06/2004 | US6716415 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of a sedative-hypnotic, such as zaleplon, zolpidem or zopiclone. |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/06/2004 | CA2084222C Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| 04/01/2004 | WO2004026875A1 Non-nucleoside reverse transcriptase inhibitors |
| 04/01/2004 | WO2004026874A1 Novel crystals of triazaspiro[5.5]undecane derivative |
| 04/01/2004 | WO2004026873A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | WO2004026872A1 Pyrazolopyridines as cyclin dependent kinase inhibitors |
| 04/01/2004 | WO2004026871A1 Novel pyrazolopyridine derivatves as pharmaceutical agents |
| 04/01/2004 | WO2004026870A1 Phenanthroline compound and organic light emitting device using same |
| 04/01/2004 | WO2004026869A1 Imidazopyridine compunds as 5-ht4 receptor agonists |
| 04/01/2004 | WO2004026868A1 N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators |
| 04/01/2004 | WO2004026867A2 Imidazopyridines as cyclin dependent kinase inhibitors |
| 04/01/2004 | WO2004026865A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026864A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | WO2004026863A1 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026859A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026819A2 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR |
| 04/01/2004 | WO2004026307A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026306A2 Pyrazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/01/2004 | WO2004002476A9 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 04/01/2004 | WO2003103666A3 4,5-dihydro-imidazo[4,5,1-j] quinolin-6-ones as parp inhibitors |
| 04/01/2004 | WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003076408A3 Indazole derivatives that are activators of soluble guanylate cyclase |
| 04/01/2004 | WO2003068148A3 Treatment of sleep disorders using sleep target modulators |
| 04/01/2004 | WO2003016563A3 Novel molecular target for neurotoxicity |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | WO2002066480A3 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063951 Alkaloid halide salts of swainsonine and methods of use |
| 04/01/2004 | US20040063949 Controlling gene expression of tranforming growth factor |
| 04/01/2004 | US20040063947 Cyclization; antitumor agents |
| 04/01/2004 | US20040063944 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 04/01/2004 | US20040063942 Spiro-indolines as Y5 receptor antagonists |
| 04/01/2004 | US20040063938 Binding to aminobutyric acid |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063932 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
| 04/01/2004 | US20040063765 Modulation of pathogenicity |
| 04/01/2004 | US20040063754 Dehalogeno compounds |
| 04/01/2004 | US20040063753 N-acetoamino-4-one-Pyridine derivatives are used as Lp-PLA2 (lipoprotein Associated Phospholipase A2) enzyme inhibitor |
| 04/01/2004 | US20040063746 For treatment of HIV |
| 04/01/2004 | US20040063745 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 04/01/2004 | US20040063744 Such as 1-(4-(1-bromo-1-phenyl-methylene)-piperidin-1-yl)-2-(4,7-dimethoxy-6 -azaindol-3-yl)-ethane-1,2-dione for treatment of HIV and acquired immune deficiency syndrome |
| 04/01/2004 | US20040063743 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via novel 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates |
| 04/01/2004 | US20040063739 Such as 6,8,13-trimethyl-8H-quino(4,3,2-kl)aridinium methyl sulphate for inhibiting telomerase, regulating cell proliferation, and treating proliferative conditions/cancer |
| 04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
| 04/01/2004 | US20040063716 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds |
| 04/01/2004 | US20040063713 Such as 2-((4-(2-fluorophenyl)-1-piperazinyl)methyl)-1H-thieno(3,4-d)imidazole |
| 04/01/2004 | US20040063705 Substituted pyrimidinyl derivatives and methods of use |
| 04/01/2004 | US20040063580 For killing weeds in paddy fields or farmlands, and are not harmful to a rice plant, wheat, barley, maize, cotton, soybeans |
| 04/01/2004 | US20040062952 Novel heterocyclic compounds, materials for light emitting devices and light emitting devices using the same |
| 04/01/2004 | US20040060478 Formed by chlorosulfonating an organic pigment and reacting with an amino carboxylic acid to form carboxy substituted sulfonamide derivatives |
| 04/01/2004 | CA2499494A1 N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators |
| 04/01/2004 | CA2499332A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | CA2499326A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | CA2498046A1 Opiate analogs selective for the delta-opioid receptor |
| 04/01/2004 | CA2497971A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | CA2497903A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | CA2497665A1 Imidazopyridine compounds as 5-ht4 receptor agonists |
| 04/01/2004 | CA2495744A1 Non-nucleoside reverse transcriptase inhibitors |
| 03/31/2004 | EP1403270A1 Pde iv inhibitors |
| 03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
| 03/31/2004 | EP1401863A1 Somatostatin-dopamine chimeric analogs |
| 03/31/2004 | EP1401838A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 03/31/2004 | EP1401836A1 Imidazo[1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections |